New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Ventas, Inc.

VTR

Real Estate Reit Healthcare Facilities

Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024.

Revenue
+23.0%
EPS
−7.14%
Free cash flow
+20.5%
Total debt
−1.07%

Quarter to September 2026, against a year earlier

86.57 0.43 −0.49%

After hours trading: 86.55, down 0.02%, last trade Fri 7:28pm Eastern.

Market cap
$47.0B
P/E
160×
Fwd P/E FY26e
169×
Dividend yield
2.36%
F-score
7/9
ROIC
2.02%
Net debt / EBITDA
5.5×
Payout ratio
3.8×

Ventas, Inc. 10-Q filed Jul 31, 2025

Fiscal Q2 2025 · Period ended Jun 30, 2025 · Filed · accepted 4:25 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed May 1, 2025: 57 added · 10 removed · 66 modified; 19 with only figures updated; 1 moved without change

  1. Modified · Company Overview

    We operate through three reportable business segments: senior housing operating portfolio, which we refer to as “SHOP,” outpatient medical and research portfolio, which we refer to as “OM&R,” and triple-net leased properties, which we refer to as “NNN.” We also hold assets outside of our reportable business segments, which we refer to as non-segment assets, and which consist primarily of corporate assets, including cash and cash equivalents, restricted cash, loans receivable and investments and accounts receivable as well as investments in unconsolidated entities. Non-segment assets include other assets such as our warrants for shares of Brookdale Senior Living, Inc. (together with its subsidiaries, “Brookdale”) and of a parent company of Kindred Healthcare, LLC (together with its subsidiaries, “Kindred”). Our investments in unconsolidated entities include investments made through our third-party institutional private capital management platform, Ventas Investment Management (“VIM”). Through VIM, we partner with third-party institutional investors to invest in real estate through various joint ventures and other co-investment vehicles where we are the sponsor or general partner, including our open-ended investment vehicle, the Ventas Life Science & Healthcare Real Estate Fund (the “Ventas Fund”). Our investments in unconsolidated entities also includes investments in operating entities, such as Ardent Health Partners, LLC (together with its subsidiaries, “Ardent”) and Atria Senior Living, Inc. (together with its subsidiaries, “Atria”).